23 September 2019 Sydney, Australia – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“ or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, announces that it will receive a milestone payment from GSK…
19 September In the US, the shift in where care is rendered is practically seismic. Almost overnight it seems (5 years in real world terms), retail clinics have become an important part of primary care and convenience is…
18 September 2019 The Hon Martin Pakula, Minister for Jobs, Innovation and Trade, recently attended the kick-off of the Medtech Actuator’s first national sprint meeting and engaged with the MedTech Actuator Accelerator Program’s fourth cohort. Following the Minister’s…
17 September 2019 When the Australian Regenerative Medicine Institute at Monash University needed help to boost industry awareness of its work and interact with the growing regenerative medicine sector, the BioMelbourne Network helped with contacts and hosted a…
17 September 2019 A Monash University student has spent five weeks conducting immersive research at the World Mosquito Program’s (WMP) Fiji site. Fiji experiences regular bouts of vector-borne disease and the program has operated there since 2018. Tanaya…
16 September 2019 Melbourne Australia: AdAlta Limited (ASX:1AD), today announced it has signed a commercial agreement for its i-body platform with global medical technology firm, GE Healthcare. Financial terms were not disclosed. The licensing deal will see the…
16 September 2019 Adelaide, Australia: Australian medical technology company LBT Innovations Limited (ASX: LBT) (LBT or the Company), a leader in medical technology automation using artificial intelligence, is pleased to announce that the Conformité Européene or CE Mark…
16 September 2019 Our industry is under attack – there is no doubt about it! The news of yet another organization falling victim to cybercrime has become a daily occurrence. As long as there is a promise of…
12 September 2019 Melbourne, Australia: Starpharma today announced that its patented clinical stage nanoparticle formulation, DEP® irinotecan, showed significantly enhanced efficacy benefits over standard irinotecan (Camptosar®) and olaparib (Lynparza®) alone and in combination, in an irinotecan-refractory HT-29 human colon cancer…
11 September 2019 Sydney, Australia – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has submitted an Orphan Drug Designation (ODD) request with the U.S. Food and Drug…
11 September 2019 New research led by Burnet Institute has demonstrated the effective use of a novel virus-like particles (VLPs) platform for malaria vaccines. The study, published in the international journal PLOS ONE, utilised a novel technology co-developed…
11 September 2019 Medtronic seeks partnership with innovating physicians in Australia and New Zealand to improve healthcare. Sydney, Australia – 11 September 2019 – Medtronic Australasia today launched Medtronic Eureka, a web-based portal for medical technology innovation designed…